Search

The article presents a study conducted by the authors on safety evaluation of ibuprofen and famotidine combination in dyspepsia patients. It mentions that combination tablets are associated with low rates of dyspepsia-related symptoms and results in side effects after discontinuation of nonsteroidal anti-inflammatory drugs (NSAID). It highlights that combination of drugs are safe and have no safety concerns to patients with gastrointestinal problems.

The article offers information on a study on safety evaluation of the combination of nonsteroidal anti-inflammatory drugs (NSAID) ibuprofen and famotidine. It mentions that the combination offers favorable gastrointestinal safety and reduced cardiovascular events as compared to ibuprofen alone. It mentions that improved discontinuation rates and reduced dyspepsia showed that the combination is safe for patients requiring long term ibuprofen therapy.